Royal Prima PT (PRIM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Royal Prima PT (PRIM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.86 Billion ≈ $108.71K USD) by net assets (Rp955.60 Billion ≈ $55.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Royal Prima PT - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Royal Prima PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PRIM total debt and obligations for a breakdown of total debt and financial obligations.

Royal Prima PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Royal Prima PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pineapple Financial Inc.
NYSE MKT:PAPL
0.089x
BR.SCH.ED.HLD.SP.ADR CL.A
F:BSK0
N/A
Enzo Biochem Inc
NYSE:ENZ
-0.074x
Genenta Science SpA ADR
NASDAQ:GNTA
0.000x
Tasman Resources Ltd
AU:TAS
-0.077x
Indbank Merchant Banking Services Limited
NSE:INDBANK
-0.033x
ViroGates A/S
CO:VIRO
-0.879x
Maheshwari Logistics Limited
NSE:MAHESHWARI
-0.136x

Annual Cash Flow Conversion Efficiency for Royal Prima PT (2014–2024)

The table below shows the annual cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Royal Prima PT.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp962.38 Billion
≈ $56.39 Million
Rp46.98 Billion
≈ $2.75 Million
0.049x +125.21%
2023-12-31 Rp981.10 Billion
≈ $57.49 Million
Rp21.27 Billion
≈ $1.25 Million
0.022x -1.33%
2022-12-31 Rp982.66 Billion
≈ $57.58 Million
Rp21.59 Billion
≈ $1.27 Million
0.022x -90.97%
2021-12-31 Rp964.21 Billion
≈ $56.50 Million
Rp234.54 Billion
≈ $13.74 Million
0.243x +259.56%
2020-12-31 Rp889.35 Billion
≈ $52.11 Million
Rp60.16 Billion
≈ $3.53 Million
0.068x +1830.15%
2019-12-31 Rp851.17 Billion
≈ $49.88 Million
Rp2.98 Billion
≈ $174.81K
0.004x -91.58%
2018-12-31 Rp848.87 Billion
≈ $49.74 Million
Rp35.33 Billion
≈ $2.07 Million
0.042x -53.08%
2017-12-31 Rp250.42 Billion
≈ $14.67 Million
Rp22.22 Billion
≈ $1.30 Million
0.089x -96.16%
2016-12-31 Rp12.13 Billion
≈ $710.64K
Rp28.02 Billion
≈ $1.64 Million
2.310x +135.31%
2015-12-31 Rp722.89 Million
≈ $42.36K
Rp-4.73 Billion
≈ $-277.14K
-6.543x -274.24%
2014-12-31 Rp-2.10 Billion
≈ $-123.29K
Rp3.68 Billion
≈ $215.54K
-1.748x --

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$16.43 Million
Rp280.40 Billion IDR
Market Cap Rank
#25610 Global
#570 in Indonesia
Share Price
Rp83.00
Change (1 day)
-3.49%
52-Week Range
Rp57.00 - Rp102.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more